Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Analysis of Population Pharmacokinetic Data

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...

Pharmacokinetic Models: Comparison and Selection Criterion

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

Pharmacokinetic Models: Overview

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comprehensive analysis of IGFL1 in colorectal cancer and its promotion of tumour progression via inhibition of lipophagy.

Frontiers in immunology·2026

Same author

Integrative chromosome-level genomics and metabolomics uncover regulatory networks linking monoterpenoid biosynthesis and glandular trichome formation in <i>Mosla chinensis</i>.

Horticulture research·2026

Same author

Global burden and cross-country inequalities of age-related eye diseases from 1990 to 2021: a comprehensive analysis of temporal trends and socioeconomic disparities.

Eye and vision (London, England)·2026

Same author

Confinement and Encapsulation of Nano-Sn in a Multimodal Porous Carbon Matrix for High-Performance Sodium-Ion Batteries.

Small (Weinheim an der Bergstrasse, Germany)·2026

Same author

Associations of relative fat mass with metabolic dysfunction-associated steatotic liver disease and liver fibrosis: evidence from the U.S. NHANES 2017-2023.

BMC gastroenterology·2026

Same author

Dynamic ctDNA Monitoring Guides Early Treatment Intensification in Locally Advanced Rectal Cancer Undergoing Neoadjuvant Chemotherapy.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Search research articles

Related Experiment Video

Updated: Jun 30, 2025

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

CPhaMAS: An online platform for pharmacokinetic data analysis based on optimized parameter fitting algorithm.

Yun Kuang¹, Dong-Sheng Cao², Yong-Hui Zuo³

¹Center of Clinical Pharmacology, The Third Xiangya Hospital, Central South University, Changsha, 410013, China; XiangYa School of Pharmaceutical Sciences, Central South University, Changsha, 410083, China.

Computer Methods and Programs in Biomedicine

|March 23, 2024

Summary

This summary is machine-generated.

CPhaMAS offers a user-friendly platform for pharmacokinetic analysis, featuring an optimized Nelder-Mead algorithm for accurate parameter estimation in drug development. This tool simplifies complex data analysis for researchers and clinicians.

Keywords:

CPhaMAS Online platform Optimized Nelder-Mead method Pharmacokinetic data analysis

More Related Videos

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

PTR-ToF-MS Coupled with an Automated Sampling System and Tailored Data Analysis for Food Studies: Bioprocess Monitoring, Screening and Nose-space Analysis

PTR-ToF-MS Coupled with an Automated Sampling System and Tailored Data Analysis for Food Studies: Bioprocess Monitoring, Screening and Nose-space Analysis

Published on: May 11, 2017

Related Experiment Videos

Last Updated: Jun 30, 2025

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Stepwise Dosing Protocol for Increased Throughput in Label-Free Impedance-Based GPCR Assays

Published on: February 21, 2020

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology

Published on: December 15, 2017

PTR-ToF-MS Coupled with an Automated Sampling System and Tailored Data Analysis for Food Studies: Bioprocess Monitoring, Screening and Nose-space Analysis

PTR-ToF-MS Coupled with an Automated Sampling System and Tailored Data Analysis for Food Studies: Bioprocess Monitoring, Screening and Nose-space Analysis

Published on: May 11, 2017

Area of Science:

Pharmacology and Drug Development
Computational Biology and Bioinformatics
Biostatistics

Background:

Clinical pharmacological modeling software is crucial but often has a steep learning curve.
Existing algorithms struggle with individual differences and measurement errors, hindering accurate pharmacokinetic parameter estimation.
There is a need for user-friendly tools with robust parameter fitting for drug development and personalized therapy.

Purpose of the Study:

To develop an optimized parameter fitting algorithm that is less sensitive to initial values.
To integrate this algorithm into a user-friendly online platform called CPhaMAS for pharmacokinetic data analysis.
To evaluate the performance and accuracy of the CPhaMAS platform compared to existing software.

Main Methods:

An optimized Nelder-Mead method was developed, featuring reinitialization of simplex vertices to avoid local solutions.
The optimized algorithm was integrated into the CPhaMAS platform, which includes modules for compartment model analysis, non-compartment analysis (NCA), and bioequivalence/bioavailability (BE/BA) analysis.
The CPhaMAS platform was evaluated and compared against the established WinNonlin software.

Main Results:

CPhaMAS demonstrated ease of use, requiring no programming knowledge.
The optimized Nelder-Mead method in CPhaMAS showed superior accuracy (lower mean relative error, higher R²) compared to WinNonlin in two-compartment and extravascular models, even with abnormal initial values.
NCA parameter calculations in CPhaMAS had a mean relative error <0.0001%, and BE calculations for various drug types showed mean relative errors <0.01% for key parameters (Cmax, AUCt, AUCinf) compared to WinNonlin.

Conclusions:

CPhaMAS is a user-friendly and accurate platform for pharmacokinetic data analysis.
The integrated optimized algorithm enhances the reliability of parameter estimation.
CPhaMAS serves as a valuable tool for drug development and precision medicine.